IL-23 p19 drugs for Crohn's Disease

4 tracked IL-23 p19 drugs in the Crohn's Disease race. The class explanation lives on the IL-23 p19 page; the full indication pipeline across every mechanism is on the Crohn's Disease page.

3 approved / phase 41 Phase 3

Head-to-head evidence: guselkumab vs JNJ-78934804 · JNJ-78934804 vs mirikizumab · JNJ-78934804 vs risankizumab · guselkumab vs mirikizumab · guselkumab vs risankizumab · mirikizumab vs risankizumab

The roster

← all IL-23 p19 drugs